Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data HNO International, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2023
FY2024
FY2025
Revenue
0.03
0.01
0
0.07
Cost of revenue
0.03
0.01
0
0
Gross profit
0.01
0.01
0
0.07
Selling and marketing
0
0
0.01
0.02
General and administrative
0.02
1.87
3.13
6.26
Operating expenses
1.08
1.91
3.32
6.53
Operating income
-1.07
-1.93
-3.34
-6.62
Interest expense
0.01
0.03
Interest income
0
0
0.01
0
Other non-operating income
0
-0.02
-0.02
-0.15
Income tax
0
0
Net income
-1.07
-1.93
-3.34
-6.62
EBITDA
-1.07
-1.89
-3.16
-6.37
EPS, basic
-0.01
-0.01
-0.01
-0.04
EPS, diluted
-0.01
-0.01
-0.01
-0.04
Shares, basic (weighted)
100
352
394
152
Shares, diluted (weighted)
100
352
394
152
Balance sheet
FY2023
FY2023
FY2024
FY2025
Cash and equivalents
0.05
0.24
0.02
0.01
Receivables
0
0.33
Other current assets
0
Total current assets
0.11
0.29
0.02
0.34
Property, plant and equipment
0
0.77
0.99
1.32
Lease right-of-use assets
0
0.12
0.06
Intangible assets
0
0.08
Other non-current assets
0
0.1
0.11
0
Total assets
0.11
1.26
1.25
1.73
Accounts payable
0
0.02
0.14
0.72
Accrued liabilities
0.01
0.04
0.03
0.06
Total current liabilities
0.63
0.87
1.99
2.77
Lease liabilities
0
0.07
0.01
Total liabilities
1.22
1.46
2.65
3.36
Paid-in capital
39
41.5
43.6
50.3
Retained earnings
-40.2
-42.1
-45.4
-52.1
Shareholders' equity
-1.11
-0.19
-1.4
-1.63
Total equity
-1.11
-0.19
-1.4
-1.63
Total liabilities and equity
0.11
1.26
1.25
1.73
Shares outstanding
105
419
419
101
Cash flow statement
FY2023
FY2023
FY2024
FY2025
Net income
-1.07
-1.93
-3.34
-6.62
Depreciation and amortization
0
0.04
0.18
0.25
Stock-based compensation
0
0.49
0.08
5.33
Change in receivables
0
-0.33
Change in payables
-0
0.02
0.12
0.23
Cash from operations
-1.12
-1.33
-1.8
-0.96
Capital expenditures
0
-0.8
-0.38
-0.23
Cash from investing
-0
-0.91
-0.41
-0.23
Stock issued
0
2.34
0.96
1.04
Cash from financing
1.17
2.43
2
1.18
Net change in cash
0.05
0.18
-0.21
-0.01
Free cash flow
-1.12
-2.14
-2.18
-1.19
Interest paid
0
0
0
0
Income taxes paid
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.03 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
100.0%
Gross profit / revenue.
Operating margin
-1,801.0%
Operating income / revenue.
EBITDA margin
-1,337.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-2,417.0%
Net income / revenue.
FCF margin
-1,047.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-933.8%
Cash from operations / revenue.
Return on assets (ROA)
-109.1%
Net income / average total assets.
Stock-based pay / revenue
98.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
113.5%
Capital expenditures / revenue.
D&A / revenue
464.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
1,446.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
23.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
11,756.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
113.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
38.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
147.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
-61.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
14.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.02x
Current assets / current liabilities.
Quick ratio
0.02x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.02x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
FCF per share
-$0.01
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$0.02
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
54.2x
Market cap / revenue.
EV/Sales
52.9x
Enterprise value / revenue.
FCF yield
-19.3%
Free cash flow / market cap.
Earnings yield
-44.6%
Net income / market cap (the inverse of P/E).
What was HNO International, Inc.'s revenue in fiscal 2025?
HNO International, Inc. reported revenue of $65.6K for fiscal 2025, 1,445.9% higher than the year before.
Was HNO International, Inc. profitable in fiscal 2025?
No. It reported a net loss of $6.6M.
How much free cash flow did HNO International, Inc. generate in fiscal 2025?
Cash from operations of $960.5K minus capital expenditures of $227.9K left free cash flow of -$1.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.